Published in Women's Health Weekly, September 22nd, 2005
The study shows a statistically significant median overall survival of 15.4 months for Taxotere versus 12.7 months for paclitaxel (HR, 1.41; 95% CI, 1.15 to 1.73; p=0.03). Taxotere and paclitaxel are agents in a class known as taxanes, which are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly